-
A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.
12 February 2013 | UCLA press release
-
A team of researchers based at Johns Hopkins has decoded a system that makes certain types of immune cells impervious to HIV infection.
22 January 2013 | Eurekalert Medicine & Health
-
The research suggests that HIV-positive people who later become co-infected with HCV are at risk for an accelerated pace of liver damage, perhaps caused by underlying immunological dysfunction.
21 January 2013 | CATIE
-
"While India has drastically reduced the spread of HIV over the past decade, new strains of the virus that cause acquired immunodeficiency syndrome (AIDS) are troubling medical scientists in this country," Inter Press Service reports (Devraj, 11/29). According to SciDev.Net, "[S]cientists have found new strains of the HIV-1 subtype C -- which is responsible for half of the world's HIV infections -- are evolving rapidly in this country."
)
03 December 2012 | Kaiser Daily Global Health Policy Report
-
New research has examined the genetic footprint that drug resistance causes in HIV and found compensatory polymorphisms that help the resistant virus to survive.
)
08 October 2012 | Science Daily
-
A nastier kind of salmonella infection has emerged alongside the HIV epidemic in Africa. The finding is the first evidence that HIV might be allowing new human pathogens to evolve in immunosuppressed people.
02 October 2012 | New Scientist
-
A new study has found that even though HIV diversifies widely within infected individuals over time, the virus strains that ultimately are passed on through heterosexual transmission often resemble the strain of virus that originally infected the transmitting partner. Learning the characteristics of these preferentially transmitted HIV strains may help advance HIV prevention efforts, particularly with regard to an HIV vaccine, according to the scientists who conducted the study.
25 September 2012 | Eurekalert Inf Dis
-
The headlines are frightening: unrelated, otherwise healthy patients in Asia turning up with symptoms doctors associate with HIV infection. But though many questions remain about the new immunodeficiency, it’s not a harbinger of a global health calamity, says Kent Sepkowitz.
28 August 2012 | Daily Beast
-
Starting antiretroviral therapy (ART) during the acute phase of HIV infection appears to reduce the number of latently infected resting CD4 T-cells in most people, but this may not be the case for individuals with very few initially infected cells, according to a study published in the May 29, 2012, advance online edition of Proceedings of the National Academy of Sciences.
14 June 2012 | HIVandHepatitis.com
-
Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody responses that block the replication of the virus compared to women who’ve only been infected once.
30 March 2012 | Science Daily
Get set for HIV treatmentA tool to help you decide whether you are ready to start taking HIV treatment.
HIV, GPs & other primary careThis booklet explains the services GPs offer, how this fits with HIV specialist care, and how to make the most of primary care services.
Treatment as prevention – free webinar 20 March 2013As
part of its European HIV prevention work, NAM is collaborating...
Microbicides research – free webinar 22 February 2013As
part of its European HIV prevention work, NAM is collaborating...
HIV treatment update – Winter 2013 21 February 2013The new edition of HIV treatment update (HTU) is on...